Posts in Dangerous Drugs

Mar 24 Orphenadrine Recall

On March 21, 2022 Sandoz announced a voluntary recall of 13 lots of its extended pain release medication Orphenadrine Citrate due ...

Mar 22 Accuretic Recall

On March 21, 2022 Pfizer announced a voluntary recall of several lots of its blood pressure medication Accuretic along with two ...

Mar 10 Zantac Litigation Update: Bellwether Case Discovery Pool Chosen

The initial discovery pool of 350 bellwether cases has been chosen in the Zantac litigation. This group of cases will undertake ...

Mar 07 Valsartan Litigation Update

With discovery on many issues being complete in the ongoing Valsartan litigation , both plaintiffs and defendants have served ...

Jan 21 Dangers of Stevens-Johnson Syndrome

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are on a continuum of severe skin reactions that are often ...

Jan 18 Pfizer’s FDA-Mandated Xeljanz Safety Clinical Trial

In January 2021, Pfizer, the manufacturer of the rheumatoid arthritis drug Xeljanz® , announced the results of the safety clinical ...